Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse × Observation × 90 days × Clear all

NCT05633615 2026-02-02

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse

NCT07310186 2025-12-30

Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy

Not yet recruiting

Lymphoma, Large B-Cell, Diffuse